The Silicon Review - Best Business Review Magazine 50 Most Trustworthy Companies 2019 | Page 45

is the pioneer and leader in molecular
diagnostics, offering innovative products
that transform patients’ lives. These
products include leading molecular
diagnostic tests for hereditary cancer,
urological cancer, autoimmune disorders,
depression, and other diseases. The firm
is excited about the future and remain
committed to advancing the science of
personalized medicine as its develop more
products to address unmet medical needs.
Myriad’s molecular diagnostic products
are designed to assess an individual’s risk
for developing disease so that action can
be taken to prevent or delay its onset.
The company’s prognostic medicine
products assess a patient’s risk of
disease progression and recurrence so
that a healthcare professional knows
how aggressively to treat the disease. Its
companion diagnostic products identify
a patient’s likelihood of responding to
a particular therapy to ensure optimal
treatment decisions.
The need to save lives and improve the
quality of life for patients is a global
imperative that knows no boundaries.
Myriad is dedicated to providing patients
and healthcare professionals around the
world with accurate, clinically valuable
information that improves, enhances and
individualizes patient care. As part of this
commitment, Myriad has established its
International Headquarters in Zurich,
Switzerland, a full-service laboratory
in Munich, Germany and sales offices in
Munich; Paris, France; Madrid, Spain;
Milan, Italy, and Zurich.
Myriad also works with a global network
of distributors to bring its transformative
molecular diagnostic tests to patients who
need them.
SR
The leading man
Mark C. Capone, President, and
CEO:
Mark C. Capone is president and CEO
of Myriad Genetics. He previously
served as president of Myriad Genetic
Laboratories from March 2010 to June
2015. Mr. Capone joined the company in
October 2002. Prior to joining Myriad,
he served 17 years with Eli Lilly and
Company where he held positions
as product development manager,
manufacturing plant manager, and area
sales director. Mr. Capone received his
B.S. degree in Chemical Engineering
from Penn State University graduating
with the highest distinction and his M.S.
degree in Chemical Engineering from
Massachusetts Institute of Technology.
He also earned a Master of Science in
Management from the Sloan School
of Management at the Massachusetts
Institute of Technology. In 2012, Mr.
Capone was elected Outstanding
Engineering Alumnus at Penn State
and is a member of the Industrial and
Professional Advisory Council along
with Advisory Board for the Hershey
Medical Center for Innovation, both
at Penn State. He currently serves on
the Board of the American Clinical
Laboratory Association and is a
Member of the Board of Trustees for
Pioneer Theatre Company in Salt Lake
City.